4B Technologies Announces Positive Phase 1 Results for Novel Non-Opioid Chronic Pain Therapy

4B Technologies announced positive topline results from a Phase 1 study of 4B03-04, a humanized monoclonal antibody for chronic pain. The trial demon...
Home/KnloSights/Clinical Trial Updates/4B Technologies Announces Positive Phase 1 Results for Novel Non-Opioid Chronic Pain Therapy